Glassman Wealth Services’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-105
Closed -$580 2019
2023
Q2
$580 Buy
105
+100
+2,000% +$538 ﹤0.01% 1605
2023
Q1
$31 Sell
5
-100
-95% -$557 ﹤0.01% 1888
2022
Q4
$489 Hold
105
﹤0.01% 1633
2022
Q3
$0 Hold
105
﹤0.01% 1777
2022
Q2
$1K Buy
105
+5
+5% +$56 ﹤0.01% 1421
2022
Q1
$2K Buy
+100
New +$2.29K ﹤0.01% 1230
2021
Q4
Sell
-100
Closed -$4K 1733
2021
Q3
$4K Hold
100
﹤0.01% 1016
2021
Q2
$4K Hold
100
﹤0.01% 974
2021
Q1
$4K Hold
100
﹤0.01% 922
2020
Q4
$4K Hold
100
﹤0.01% 902
2020
Q3
$6K Buy
+100
New +$5.29K ﹤0.01% 732

Other funds holding GDRX

Glassman Wealth Services's GDRX Position: Q3 2023 in Review

Glassman Wealth Services sold out of GoodRx Holdings (GDRX) in Q3 2023, closing a stake of 105 shares — an estimated $580 sold.

Glassman Wealth Services first reported a position in GDRX in Q3 2020 and held it in 11 quarters. The position peaked at $6K in Q3 2020. 155 funds tracked by Wall St. Rank hold GDRX as of Q3 2023.

  • Glassman Wealth Services reported no remaining GoodRx Holdings position as of Q3 2023 after selling out during the quarter.
  • Glassman Wealth Services sold 105 GoodRx Holdings shares in Q3 2023, an estimated $580.
  • Glassman Wealth Services first reported a position in GoodRx Holdings in Q3 2020 and held it in 11 quarters.
  • Glassman Wealth Services's GoodRx Holdings position peaked at $6K in Q3 2020.
  • 155 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2023.

Based on Glassman Wealth Services's 13F filing for Q3 2023, filed 14 Nov 2023.